“Beyond Weight Loss: Practical Considerations for Use of Glucagon Like Peptide-1 (GLP-1) and Incretin Therapy in Inflammatory Skin Disease”. Canadian Dermatology Today, vol. 7, no. 3, Sept. 2026, pp. 11-16, https://doi.org/10.58931/cdt.2026.73168.